SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development

被引:62
作者
Swat, W
Fujikawa, K
Ganiatsas, S
Yang, D
Xavier, RJ
Harris, NL
Davidson, L
Ferrini, R
Davis, RJ
Labow, MA
Flavell, RA
Zon, LI
Alt, FW [8 ]
机构
[1] Harvard Univ, Sch Med, Ctr Blood Res, Dept Genet, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Gastroenterol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Mol Biol, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[6] Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA
[7] Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01605 USA
[8] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA
[9] Hoffmann La Roche Inc, Nutley, NJ 07110 USA
关键词
D O I
10.1016/S1074-7613(00)80567-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
SAPK is a member of the group of evolutionary conserved stress-activated kinases that mediate control of cellular death and proliferation. In lymphocytes, the SAPK pathway has been implicated in signaling from antigen, costimulatory, and death receptors; SEK1, which directly activates SAPK, is required for early embryonic development and has also been reported to be essential for normal lymphocyte development. In contrast to the latter findings, we have used RAG-2-deficient blastocyst complementation to show that SEK1-deficient embryonic stem cells support unimpaired T and B lymphocyte development. Moreover, mature SEK1-deficient lymphocytes are capable of SAPK activation. Surprisingly, however, aging SEK1-deficient chimeric mice frequently develop lymphadenopathy and polyclonal B and T cell expansions. Thus, SEK1 is not required for lymphocyte development, but is required for maintaining peripheral lymphoid homeostasis.
引用
收藏
页码:625 / 634
页数:10
相关论文
共 66 条
[1]   Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases [J].
Berberich, I ;
Shu, G ;
Siebelt, F ;
Woodgett, JR ;
Kyriakis, JM ;
Clark, EA .
EMBO JOURNAL, 1996, 15 (01) :92-101
[2]   INCREASED T-CELL APOPTOSIS AND TERMINAL B-CELL DIFFERENTIATION-INDUCED BY INACTIVATION OF THE ETS-1 PROTOONCOGENE [J].
BORIES, JC ;
WILLERFORD, DM ;
GREVIN, D ;
DAVIDSON, L ;
CAMUS, A ;
MARTIN, P ;
STEHELIN, D ;
ALT, FW .
NATURE, 1995, 377 (6550) :635-638
[3]   DYSREGULATED INTERLEUKIN-6 EXPRESSION PRODUCES A SYNDROME RESEMBLING CASTLEMANS DISEASE IN MICE [J].
BRANDT, SJ ;
BODINE, DM ;
DUNBAR, CE ;
NIENHUIS, AW .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (02) :592-599
[4]   NEUTROPHIL AND B-CELL EXPANSION IN MICE THAT LACK THE MURINE IL-8 RECEPTOR HOMOLOG [J].
CACALANO, G ;
LEE, J ;
KIKLY, K ;
RYAN, AM ;
PITTSMEEK, S ;
HULTGREN, B ;
WOOD, WI ;
MOORE, MW .
SCIENCE, 1994, 265 (5172) :682-684
[5]   Thymocyte development is normal in CTLA-4-deficient mice [J].
Chambers, CA ;
Cado, D ;
Truong, T ;
Allison, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) :9296-9301
[6]   Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation [J].
Chan, VWF ;
Meng, FY ;
Soriano, P ;
DeFranco, AL ;
Lowell, CA .
IMMUNITY, 1997, 7 (01) :69-81
[7]   Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells [J].
Chauhan, D ;
Kharbanda, S ;
Ogata, A ;
Urashima, M ;
Teoh, G ;
Robertson, M ;
Kufe, DW ;
Anderson, KC .
BLOOD, 1997, 89 (01) :227-234
[8]  
CHEN J, 1994, TRANSGENESIS TARGETE, P35
[9]   RAG-2-DEFICIENT BLASTOCYST COMPLEMENTATION - AN ASSAY OF GENE-FUNCTION IN LYMPHOCYTE DEVELOPMENT [J].
CHEN, JZ ;
LANSFORD, R ;
STEWART, V ;
YOUNG, F ;
ALT, FW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (10) :4528-4532
[10]   LPR AND GLD - SINGLE GENE MODELS OF SYSTEMIC AUTOIMMUNITY AND LYMPHOPROLIFERATIVE DISEASE [J].
COHEN, PL ;
EISENBERG, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 :243-269